Stacy Feld, Head, Johnson & Johnson Innovation, West North America, Australia & New Zealand, Johnson & Johnson Innovation (JLABS)
Stacy is Head of Johnson & Johnson Innovation, West North America, Australia & New Zealand, located at the Innovation Center in South San Francisco, California. In this role, she leads the Innovation Center team to build, advance, and manage a portfolio of co-investments and collaborations spanning the pharmaceutical, consumer health and medical device sectors. Stacy is also responsible for expanding and nurturing the external networks within the innovation community, including academia, venture capital, entrepreneurs and other governmental and private organizations.
Stacy has more than twenty years of diverse business experience translating innovative science and technology into transformative commercial solutions for patients and consumers. She has held a range of leadership positions in the healthcare, biotech, life sciences and consumer health sectors as a business development executive, venture capital investor, business and innovation strategist and transactional attorney.
Prior to her position as Head of Johnson & Johnson Innovation, West North America, Australia & New Zealand, Stacy was Vice President of Consumer Venture Investments and External Innovation and a team member of Johnson & Johnson Innovation – JJDC, Inc. (JJDC). During her three-year tenure at JJDC, Stacy was globally responsible for the growth and management of the Consumer Health equity portfolio and led consumer health and health technology venture investing on the investment team. Under her leadership, the Consumer Health portfolio grew threefold, adding innovative scientific and technological solutions including branded consumer health products and digital health solutions.
Stacy joined Johnson & Johnson Innovation in 2014 as the Senior Director of Consumer Scientific Innovation at the California Innovation Center, where she was responsible for the identification, assessment and execution of partnerships and collaborations to onboard strategic value assets for the Consumer Health sector.
Prior to joining Johnson & Johnson, Stacy was a partner at Physic Ventures, a venture capital firm investing in health and sustainability, where she led investments in personalized health solutions that empower consumers to improve their health and wellbeing. Stacy has also been active in the design and execution of science-enabled innovation strategies, business incubation and spin-off opportunities, advising senior management of global enterprises in the consumer product goods industry and pre-commercial and commercial-stage start-ups in the personalized health and medical technology sectors. Prior to joining Physic Ventures, Stacy held leadership positions in the business development groups at Genentech and Third Wave Technologies and was a technology transactions attorney at Wilson, Sonsini, Goodrich & Rosati.
Stacy is an advisor to Springboard Enterprises’ Life Sciences Council, UCSF Clinical and Translational Research Institute T1 Catalyst Program, a mentor for C-Sweetener and a member of the Advisory Council for the University of Texas Horizon Fund and the Investment Advisory Committee for the Reproductive Health Investors Alliance. Stacy has been recognized by Pharm Exec as a 2016 Emerging Leader and in 2018 was named in the Top 10 Global Corporate Venturing Rising Stars.
Stacy earned her B.A. in Sociology from the University of Pennsylvania and received her J.D. from Vanderbilt Law School.